Document:

Exhibit 10.24

 

EXECUTION VERSION

 

sECURITIES
aCQUISITION AGREEMENT

 

This SECURITIES ACQUISITION AGREEMENT
(this “Agreement”) is entered into as of July 28, 2017 by and among Mimesis Capital Partners LLC (“Mimesis”),
PJC Investments, LLC, a Texas limited liability company (“PJC”) and Triax Capital Advisors LLC, a New York limited
liability company (“Triax”). Each of PJC and Triax may also be referred to herein individually as a “Party”
and collectively as the “Parties”.

 

WHEREAS, PJC is party to Master Transaction
Agreements, dated as of March 15, 2017 and May 12, 2017, as amended to date and from time to time (the “MTAs”;
capitalized terms not otherwise defined in this Agreement shall have the meanings assigned to them in the MTAs), by and among Emergent
Capital, Inc. (the “Company”), PJC and the Consenting Convertible Note Holders party(ies) thereto (“Consenting
Convertible Note Holders”) relating to the recapitalization of the Company; and

 

WHEREAS, pursuant to the MTAs, the Parties
will designate one or more party(ies) (collectively, the “Investor”) to be party(ies) to certain other agreements,
including the Senior Note Purchase Agreement, the Common Stock Purchase Agreement, the Registration Rights Agreement and/or the
Warrant (each an “Operative Agreement”; and collectively, the “Operative Agreements”); and

 

WHEREAS, Mimesis
wishes that it be designated, and the Parties wish to designate Mimesis as an Investor with
respect to certain rights and obligations under the Operative Agreements in accordance with the terms and conditions of this Agreement;
and

 

NOW, THEREFORE, in consideration of the mutual
covenants herein contained, and for such other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto hereby agree as follows:

 

1.           Designations by the Parties.
The Parties hereby agree with Mimesis that it will cause Mimesis to be designated as an Investor with respect to the following
rights and obligations under the Operative Agreements:

 

(a)         Senior Note Purchase Agreement.
The Parties will cause Mimesis to be designated as an Investor to purchase $1,500,000 in aggregate principal amount of the New
Senior Notes, as set forth on Schedule I, from the sellers thereof pursuant to the Senior Note Purchase Agreement.

 

(b)         Common Stock Purchase Agreement.
PJC will cause Mimesis to be designated as an Investor to purchase 2,500,000 Shares, for a purchase price of $0.20 per share or
an aggregate purchase price of $500,000, from the Company pursuant to the Common Stock Purchase Agreement.

 

(c)         Warrant. The Parties will cause
Mimesis to be designated as an Investor to receive Warrants to purchase an aggregate of 600,000 Warrant Shares, as set forth on
Schedule I, at an exercise price of $0.20 per Warrant Share, which Warrants shall vest pursuant to Section 2(b)(ii) of the Warrant,
on a pro rata basis with the 25,000,000 Warrant Shares vesting pursuant to such Section 2(b)(ii).

 

     

     

    

 

2.           Entry into Operative Agreements
by Mimesis. Mimesis agrees that, in connection with the Closing, it will enter into and perform their obligations under each
of the Operative Agreements as applicable with respect to the designations set forth in Section 1 of this Agreement.

 

3.           Notes Option. The Parties and
Mimesis agree that, at any time after the issuance of the New Senior Notes until the date that is the eighteenth month anniversary
thereof (the “Option Period”), the Parties shall have the option (the “Notes Option”) to
require Mimesis to sell to the Parties, allocated equally between them, all or a portion of the New Senior Notes purchased pursuant
to Section 1(a) of this Agreement and then held by Mimesis (all such New Senior Notes, the “Mimesis Notes”)
at an aggregate purchase price equal to the outstanding principal amount of the Mimesis Notes for which the Notes Option is being
exercised plus any accrued and unpaid interest thereon (the “Exercise Price”), all in accordance with the provisions
of this Section 3.

 

(a)         Exercise of Option. The Parties,
at their option and in their sole discretion, may at any time and from time to time during the Option Period, exercise the Notes
Option, in whole or in part, by delivering in writing to Mimesis a notice (an “Exercise Notice”) stating that
the Parties are exercising their Notes Options, which Exercise Notice shall set forth the aggregate principal amount of the Mimesis
Notes for which the Notes Option is being exercised. However, without the prior written consent of Mimesis, at no time shall the
Parties exercise their Notes Option:

 

		(i)	for an amount less than $500,000 of outstanding principal amount of Mimesis Notes; or

 

		(ii)	for an amount that would cause Mimesis to hold an amount in aggregate principal amount of Mimesis Notes that is greater than
$0 and less than $500,000 in aggregate principal amount.

 

(b)         Remaining Mimesis Notes. If
at the end of the Exercise Period Mimesis still holds any Mimesis Notes, the Parties shall purchase such remaining Mimesis Notes
and such purchase shall be treated under Section 3(c) below as a closing of an exercise of the Notes Option, with the final date
of the Exercise Period serving as the date of the Exercise Notice therefor.

 

(c)         Closing.

 

		(i)	The closing of any exercise of the Notes Option shall be on the tenth (10th) Business Day after the date of the
Exercise Notice (the “Exercise Date”), or such other date as mutually agreed upon by the Parties and Mimesis
(the “Option Closing Date”).

 

     

     

    

 

		(ii)	On or before the Option Closing Date, the Parties shall pay the Exercise Price for the Mimesis Notes being purchased (the “Purchased
Mimesis Notes”) by wire transfer of immediately available funds to Mimesis pursuant to instructions to be provided by
Mimesis, and upon request of Mimesis, to execute and deliver any additional documents deemed by Mimesis to be necessary or desirable
to transfer the Purchased Mimesis Notes, including without limitation as may be necessary to register the transfer in accordance
with the New Senior Notes Indenture. On or before the Option Closing Date, Mimesis shall deliver or cause to be delivered to the
Parties the Purchased Mimesis Notes in such form that good and marketable title thereto passes to the Parties upon such delivery,
free and clear of any Liens or taxes.

 

(d)         Terms of Exchange. The Parties
agree that if any Mimesis Notes are purchased by the Parties pursuant to the exercise of a Notes Option under this Section 3, then

 

		(i)	the Parties shall not, without Mimesis’s prior written consent, directly or indirectly exchange Purchased Mimesis Notes
for Common Stock, or any other security having its value derived directly from the value of Common Stock (“Equity-Like
Securities”), in a single-step or multiple-step transaction with the Company (an “Exchange”) which
would have the direct or indirect effect of providing either Party with Common Stock or Equity-Like Securities at an effective
price of less than the greater of (a) the volume-weighted average price of Common Stock for the fifteen trading days immediately
preceding the Exercise Date as reported by Bloomberg Financial Services; and (b) $0.20 per share of Common Stock (as adjusted from
time to time to reflect any stock dividends, stock splits, recapitalizations or similar transactions occurring after the Closing);
and

 

		(ii)	so long as Mimesis still holds any Mimesis Notes acquired at the Closing, the Parties shall not directly or indirectly partcipate
in an Exchange with respect to the Purchased Mimesis Notes unless Mimesis is offered the opportunity to participate in such Exchange
with respect to any Mimesis Notes it acquired at the Closing and still at the time holds, on substantially the same terms and conditions
as the Parties.

 

For avoidance of doubt, Equity-Like Securities shall
include, without limitation, warrants to purchase Common Stock and debt securities convertible into Common Stock.

 

(e)         Right of First Refusal. Nothing
in Section 3 shall prohibit or otherwise restrict Mimesis from selling or transferring any Mimesis Notes to a third party in accordance
with applicable law and Section 2.04 of the New Senior Notes Indenture; provided, however, that in the event that Mimesis
intends to effect such a sale or other transfer during the Option Period, then the Parties shall have a right of first refusal
to purchase such Mimesis Notes proposed to be so transferred or sold (the “Transfer Notes”) on the terms and
conditions set forth in this Section 3(e).

 

		(i)	Notice of Proposed Transfer. At least five (5) business days in advance of a proposed transfer, Mimesis shall deliver
to each Party a written notice (the “Transfer Notice”) stating: (A) Mimesis’s bona fide intention to sell
or otherwise transfer such Transfer Notes; (B) the principal amount of the Transfer Notes to be transferred to each Proposed Transferee;
and (C) the terms and conditions, including the proposed closing date, of each proposed sale or transfer. Mimesis shall offer the
Transfer Notes at the same price (the “Purchase Price”) and upon the same terms (or terms as similar as reasonably
possible) to the Parties, allocated equally between them.

 

     

     

    

 

		(ii)	Exercise of Right of First Refusal. At any time within five (5) business days after receipt of the Transfer Notice,
the Parties may by giving written notice to Mimesis, elect to purchase all, but not less than all, of the Transfer Notes proposed
to be transferred to the Proposed Transferee(s), at the Purchase Price. If the terms of the proposed transfer in the Transfer Notice
include consideration other than cash, the cash equivalent value of the non-cash consideration shall be determined jointly by Mimesis
and the Parties in good faith.

 

		(iii)	Payment and Transfer. On or before the closing date set forth in the Transfer Notice or such other date as may be mutually
agreed by Mimesis and the Parties, (i) the Parties shall make payment of the Purchase Price in cash by wire transfer of immediately
available funds pursuant to instructions to be provided by Mimesis to the Parties, (ii) upon request of Mimesis, the Parties shall
execute and deliver any additional documents deemed by Mimesis to be necessary or desirable to transfer the Transfer Notes, including
without limitation as may be necessary to register the transfer in accordance with the New Senior Notes Indenture, and (iii) Mimesis
shall deliver to the Parties the Transfer Notes in such form that good and marketable title thereto passes to the Parties upon
such delivery, free and clear of any Liens or taxes.

 

4.           Representations and Warranties.

 

(a)         Representations and Warranties of
Mimesis. Mimesis hereby represents and warrants to, and agrees with, the Parties, as of the date hereof and as of the Closing
Date, as follows:

 

		(i)	Organization, Authority, Execution and Enforceability. Mimesis is duly organized, validly existing and in good standing
under the laws of its jurisdiction of organization and has the right, power and authority to execute and deliver this Agreement
and the Operative Agreements to which it will be a party and to consummate the transactions contemplated hereby and thereby, as
applicable. This Agreement has been duly authorized, executed and delivered by Mimesis and constitutes the valid and binding obligation
of Mimesis, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency, fraudulent
transfer, moratorium or other similar laws relating to or affecting the rights of creditors generally and by equitable principles,
including those limiting the availability of specific performance, injunctive relief and other equitable remedies and those providing
for equitable defenses. Each Operative Agreement, when executed and delivered by Mimesis, will be duly authorized, executed and
delivered by Mimesis and will constitute the valid and binding obligation of Mimesis enforceable in accordance with its terms,
except as enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium or other similar laws relating
to or affecting the rights of creditors generally and by equitable principles, including those limiting the availability of specific
performance, injunctive relief and other equitable remedies and those providing for equitable defenses.

 

     

     

    

 

		(ii)	Investment Representations. Mimesis is an "accredited investor" as defined in Rule 501(a) promulgated under
the U.S. Securities Act of 1933, as amended (the "Securities Act"), and has such knowledge and experience in financial
and business matters that it is capable of evaluating the merits and risks of the transactions contemplated under this Agreement
and the Operative Agreements. Mimesis will be acquiring the New Senior Notes, Common Stock and Warrant for investment purposes
and not with a view to, or for resale in connection with, any distribution of the New Senior Notes, Common Stock or Warrant. Mimesis
has the capacity to evaluate the merits and risks of its investment in the New Senior Notes and Warrant and to bear all economic
risks of investment in the New Senior Notes and Warrant, including a complete loss of its investment. Mimesis has had the opportunity
to review such disclosure regarding the Company, its business, its financial condition and its prospects, including the Company's
publicly available SEC filings, as it has determined to be necessary in connection with the purchase of the New Senior Notes and
the Warrant. Mimesis acknowledges that neither Party has made any representation to the accuracy or completeness of any of the
SEC filings of the Company.

 

		(iii)	Exempted Transaction. Mimesis acknowledges that the New Senior Notes, Common Stock and Warrant are being offered and
sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities
laws, have not been registered under the Securities Act or the securities laws of any state, and will be "restricted securities"
as said term is defined in Rule 144 of the rules and regulations promulgated under the Securities Act.

 

		(iv)	Consents and Approvals. No consent, approval, authorization or order of, or filing with, any governmental body or any
court is required to be obtained or made by Mimesis for the consummation of the transactions contemplated by this Agreement and
the Operative Agreements.

 

		(v)	No Violation of Law or Agreement. Neither the execution and delivery of this Agreement or any Operative Agreements by
Mimesis, nor the consummation of the transactions contemplated hereby or thereby by Mimesis, will violate any judgment, order,
writ, decree, law, rule or regulation or agreement applicable to Mimesis.

 

     

     

    

 

		(vi)	Ownership. At any Option Closing, Mimesis will be the legal and beneficial owner of Mimesis Notes being purchased, duly
authorized to convey such Mimesis Notes to the Parties and will convey to the Parties good and marketable title to the Purchased
Mimesis Notes being so transferred, free and clear of any Liens or taxes.

 

(b)         Representations and Warranties of
the Parties. Each Party, severally and not jointly, hereby represents and warrants, and agrees with, Mimesis, as to itself
as of the date hereof and as of the Exercise Date, as follows:

 

		(i)	Organization, Authority, Execution and Enforceability. Each Party is duly organized, validly existing and in good standing
under the laws of its respective jurisdiction of organization and has the right, power and authority to execute and deliver this
Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered
by each Party and constitutes the valid and binding obligation of such Party, enforceable in accordance with its terms, except
as enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium or other similar laws relating to or
affecting the rights of creditors generally and by equitable principles, including those limiting the availability of specific
performance, injunctive relief and other equitable remedies and those providing for equitable defenses.

 

		(ii)	Investment Representations. Each Party is an “accredited investor” as defined in Rule 501(a) promulgated
under the Securities Act, and has or will have such knowledge and experience in financial and business matters that it is capable
of evaluating the merits and risks of the transactions contemplated under this Agreement. Each Party, upon an exercise of the Notes
Option, will be acquiring the Mimesis Notes for investment purposes, and not with a view to, or for resale in connection with,
any distribution of such Mimesis Notes. Each Party has the capacity to evaluate the merits and risks of its investment in the Mimesis
Notes and to bear all economic risks of investment in the Mimesis Notes, including a complete loss of its investment. Each Party
has had the opportunity to review such disclosure regarding the Company, its business, its financial condition and its prospects,
including the Company’s publicly available SEC filings, as it has determined to be necessary in connection with the purchase
of the Mimesis Notes. Each Party acknowledges that Mimesis has not made any representation to the accuracy or completeness of any
of the SEC filings of the Company.

 

     

     

    

 

		(iii)	Exempted Transaction. Each Party acknowledges that the Mimesis Notes are being offered and sold to it in reliance on
specific exemptions from the registration requirements of United States federal and state securities laws, have not been registered
under the Securities Act or the securities laws of any state, and will be “restricted securities” as said term is defined
in Rule 144 of the rules and regulations promulgated under the Securities Act.

 

		(iv)	Consents and Approvals. No consent, approval, authorization or order of, or filing with, any governmental body or any
court is required to be obtained or made by either Party for the consummation of the transactions contemplated by this Agreement,
other than the written approval of the Florida Office of Insurance Regulation, if applicable.

 

		(v)	No Violation of Law or Agreement. Neither the execution and delivery of this Agreement by either Party, nor the consummation
of the transactions contemplated hereby by either Party, will violate any judgment, order, writ, decree, law, rule or regulation
or agreement applicable to either Party.

 

5.           Board Observation. PJC shall
use its best efforts to cause the Company’s board of directors to offer board observation rights to at least two designees
of Mimesis, though such designees need not necessarily be members of Mimesis, for so long as (i) Mimesis shall continue to hold
any New Senior Notes or (ii) the Company’s board deems such observation rights to be beneficial to the Company; provided
that Mimesis acknowledges that such observation rights will not permit such designees of Mimesis to vote on any action taken by
the Company’s board of directors. Any such offer shall be subject to the acceptance of such designees in their respective
capacities.

 

6.           Miscellaneous.

 

(a)         Survival of Representations, Warranties
and Covenants. The representations, warranties and covenants of each party contained herein shall survive the Closing and the
closing of any exercise of the Notes Option. Each party may rely on such representations, warranties and covenants irrespective
of any investigation made, or notice or knowledge held by, it or any other Person.

 

(b)         Notices. All notices and other
communications hereunder shall be in writing and shall be deemed to have been duly given when delivered in person or by an overnight
courier service, or sent via facsimile transmission and verification received, or five (5) Business Days after being posted by
the United States postal service, registered or certified mail, return receipt requested with first class postage prepaid.

 

(c)         Assignment. This Agreement shall
not be assigned by either party without the prior written consent of the other party. Any purported assignment without such consent
shall be null and void.

 

(d)         Severability. Any provision
of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the
extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

     

     

    

 

(e)         Further Assurances. From and
after the date hereof, upon the reasonable request of any party hereto, the other parties will, and shall cause their respective
Affiliates to, execute and deliver such instruments, documents or other writings, and to do such other acts and things, as may
be necessary or reasonable to confirm and carry out and to effectuate fully the intent and purposes of this Agreement.

 

(f)          Entire Agreement. This Agreement
and the Operative Agreements constitute the entire agreement by the parties hereto and supersede any other agreement, whether written
or oral, that may have been made or entered into between them relating to the matters contemplated hereby.

 

(g)         Amendments and Waivers. This
Agreement may be amended, modified, superseded, or canceled, and any of the terms, representations, warranties or covenants hereof
may be waived, only by written instrument executed by the parties hereto or, in the case of a waiver, by the party waiving compliance.

 

(h)         Expenses. Each of the parties
agrees to pay its own expenses incident to this Agreement and the performance of its obligations hereunder.

 

(i)          Governing Law; Submission to Jurisdiction;
Waiver of Jury Trial. This Agreement shall be governed by and construed in accordance with the laws of the State of New York
without regard to conflicts of laws principles that would require the application of laws of any other jurisdiction. Any legal
action or proceeding in connection with this Agreement or the performance hereof shall be brought in the state and federal courts
located in the Borough of Manhattan, City, County and State of New York, and the parties hereby irrevocably submit to the exclusive
jurisdiction of such courts for the purpose of any such action or proceeding and agrees not to assert, by way of motion, as a defense
or otherwise, in any such action or proceeding, any claim that such party is not subject personally to the jurisdiction of the
above-named courts, that any such action or proceeding may not be brought or maintained in one of the above-named courts should
be dismissed on the grounds of forum non conveniens, should be transferred to any court other than one of the above-named courts,
or that this Agreement or the subject matter hereof may not be enforced in or by any of the above-named courts. Each of the parties
hereto hereby consents to service of process in any such action or proceeding in any manner permitted by the laws of the State
of New York, agrees that service of process by registered or certified mail, return receipt requested, pursuant to Section 5(b)
is reasonably calculated to give actual notice and waives and agrees not to assert by way of motion, as a defense or otherwise,
in any such action, suit or proceeding any claim that service of process made in accordance with this Section 5(i) does not constitute
good and sufficient service of process. THE PARTIES WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY DISPUTE ARISING UNDER OR IN CONNECTION
WITH THIS AGREEMENT.

 

(j)          Counterparts. This Agreement
may be executed in one or more counterparts (including by facsimile or other electronic transmission), each of which shall be an
original, but all of which together shall constitute one and the same instrument.

 

     

     

    

 

IN WITNESS WHEREOF, the parties have caused
this Agreement to be duly executed as of the date first above written.

 

	PJC Investments, LLC	 	TRIAX CAPITAL ADVISORS LLC
	 	 	 	 	 	 	 
	By:	/s/ Patrick J. Curry	 	By:	/s/ Joseph E. Sarachek
	 	Name:	Patrick J. Curry	 	 	Name:	Joseph E. Sarachek
	 	Title:	Manager	 	 	Title:	Managing Partner  
	 	 	 	 	 	 	 
	MIMESIS CAPITAL PARTNERS LLC	 	 	 	 
	 	 	 	 	 	 	 
	By:	/s/ Matthew D. Houk	 	 	 	 
	 	Name:	Matthew D. Houk 	 	 	 	 
	 	Title:	Authorized PersonExhibit 10.25

 

Execution Version

 

rights
PURCHASE AGREEMENT

 

This RIGHTS PURCHASE
AGREEMENT (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”)
is entered into as of July 6, 2017 by and among Ironsides P Fund L.P. and Ironsides Special Situations Master Fund II L.P. (each,
a “Seller” and collectively, the “Sellers”) and PJC Investments, LLC, a Texas limited liability
company (the “Purchaser”).

 

WHEREAS, each Seller is the beneficial owner
of certain 8.50% Senior Unsecured Convertible Notes due 2019 (the “Convertible Notes”) issued by Emergent Capital,
Inc. (the “Company”); and

 

WHEREAS, the Company has offered, pursuant
to the Offer to Exchange, dated April 18, 2017 (the “Exchange Offer”), for each $1,000 in principal amount
of Convertible Notes accepted for exchange in the Exchange Offer, (i) new 5.0% Senior Unsecured Convertible Notes due 2023 (the
“New Convertible Notes”) and (ii) the right to purchase shares of its common stock, par value $0.001 per share
(the “Common Stock”); and

 

WHEREAS, as a result of the Exchange Offer,
for each $1,000 in principal amount of Convertible Notes accepted for exchange in the Exchange Offer, each Seller will receive
(i) New Convertible Notes and (ii) the right (the “Exchange Common Stock Purchase Rights”) to purchase shares
of Common Stock (the “Shares”); and

 

WHEREAS, each Seller has agreed, pursuant
to the Master Transaction Agreement (as defined below), to tender all the Convertible Notes beneficially owned by it into the
Exchange Offer and receive, among other things, the Exchange Common Stock Purchase Rights; and

 

WHEREAS, each Seller desires to sell to the
Purchaser, and the Purchaser desires to purchase from each Seller, the Exchange Common Stock Purchase Rights and, in connection
therewith, purchase Shares issued by the Company, in accordance with the terms and conditions of this Agreement.

 

NOW, THEREFORE, in consideration of the mutual
covenants herein contained, and for such other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto hereby agree as follows:

 

1.     Convertible
Note TENDER

 

1.1.        Convertible
Note Tender. Each Seller has entered into that certain master transaction agreement dated March 15, 2017 (as amended, restated,
amended and restated, supplemented or otherwise modified from time to time, the “Master Transaction Agreement”)
by and among the Company, the Purchaser, and each Seller. Each Seller has tendered or will tender, in accordance with the Master
Transaction Agreement, 100% of the principal amount of all Convertible Notes beneficially owned by such Seller into the Exchange
Offer and, as a result, is or will be entitled to the Exchange Common Stock Purchase Rights with respect to the Convertible Notes
beneficially owned by such Seller that are accepted by the Company in the Exchange Offer.

 

     

     

    

 

2.     SALE
OF RIGHTS

 

2.1.        Sale
of Exchange Common Stock Purchase Right. Each Seller hereby sells to, and the Purchaser hereby purchases, all of such Seller’s
right, title and interest in all of the Exchange Common Stock Purchase Rights held by such Seller. The aggregate purchase price
for the Exchange Common Stock Purchase Rights shall consist of a warrant or warrants in the form of the Warrant attached as Exhibit
E to the Master Transaction Agreement, (as modified by Amendment No. 1 and Amendment No. 2, the “Warrant(s)”)
issued in the name of the Sellers and/or their designee(s) at the direction of the Sellers, to purchase 2,000,000 shares of Common
Stock subject to the terms and conditions set forth in the Warrant and, notwithstanding the foregoing, having the vesting rights
described in Section 2(b)(ii) thereof (the “Purchase Price”). 

 

2.2.        Closing
of Sale of Exchange Common Stock Purchase Rights. At the Closing (as defined in the Master Transaction Agreement), Purchaser
shall cause to be delivered to the Sellers the Purchase Price in the form of one or more Warrants issued to the Sellers or their
designee(s) at the direction of the Sellers.

 

2.3.        Procedures.
In connection with the sale of the Exchange Common Stock Purchase Rights by the Sellers to the Purchaser and in order to facilitate
the sale and issuance of the Shares to the Purchaser or its designee(s), the parties hereto agree that:

 

		2.3.1.	The Purchaser hereby directs the Sellers, for the benefit
                                         of the Purchaser, to (i) indicate on the Letter of Transmittal submitted by the Sellers
                                         in connection with the Exchange Offer or (ii) make such elections with their prime brokers
                                         in connection with the Exchange Offer, in either case, in order to subscribe for a Full
                                         Allotment (as defined in the Exchange Offer) and an Additional Full Allotment (as defined
                                         in the Exchange Offer) in connection with the exercise of the Exchange Common Stock Purchase
                                         Rights.

 

		2.3.2.	After the Sellers receive notice from the Company regarding
                                         the amount of Shares allocated to the Sellers for the benefit of the Purchaser in connection
                                         with the exercise of the Exchange Common Stock Purchase Rights described above, the Sellers
                                         shall provide such notice (or a copy thereof) to the Purchaser. Upon receipt of such
                                         notice (or copy thereof), the Purchaser or its designee(s), if any, will provide for
                                         the payment of the purchase price for the Shares allocated to the Sellers for the benefit
                                         of the Purchaser in connection with the exercise of the Exchange Common Stock Purchase
                                         Rights described above in accordance with procedures set forth in the Exchange Offer
                                         and the Letter of Transmittal or as otherwise directed or permitted by the Company and
                                         the Information and Exchange Agent (as defined in the Exchange Offer). For the avoidance
                                         of doubt, the Company, the Purchaser and the Sellers acknowledge and agree that the Purchaser
                                         shall be solely liable for the payment to the Company in respect of the Shares allocated
                                         to the Sellers for the benefit of the Purchaser in connection with the exercise of the
                                         Exchange Common Stock Purchase Rights described above and the Sellers will have no obligation
                                         hereunder to provide for any payment to the Company in respect of the Shares allocated
                                         to the Sellers for the benefit of the Purchaser in connection with the exercise of the
                                         Exchange Common Stock Purchase Rights described above.

 

    	 	2	 

     

    

 

		2.3.3.	The Sellers will indicate, when and as appropriate to the
                                         Information and Exchange Agent and/or the Company with respect to the concurrent settlement
                                         of the Exchange Offer and the Closing, to have the Shares allocated to the Sellers for
                                         the benefit of the Purchaser in connection with the exercise of the Exchange Common Stock
                                         Purchase Rights described above issued by the Company directly to the Purchaser and/or
                                         its designee(s) upon payment for such shares by the Purchaser and/or its designee(s).
                                         For the avoidance of doubt, the Company, the Purchaser and the Sellers acknowledge and
                                         agree that any Shares allocated to the Sellers for the benefit of the Purchaser in connection
                                         with the exercise of the Exchange Common Stock Purchase Rights described above shall
                                         be issued by the Company directly to the Purchaser and/or its designee(s).

 

3.     REPRESENTATIONS,
WARRANTIES AND Covenants

 

3.1.        Representations
and Warranties of the Sellers. Each Seller, severally and not jointly, hereby represents and warrants as to itself, and agrees
with, the Purchaser as follows:

 

		3.1.1.	Organization, Authority, Execution and Enforceability.
                                         Such Seller is duly organized, validly existing and in good standing under the laws of
                                         its jurisdiction of organization and has the right, power and authority to execute and
                                         deliver this Agreement and to consummate the transactions contemplated hereby. This Agreement
                                         has been duly authorized, executed and delivered by such Seller and constitutes the valid
                                         and binding obligation of such Seller, enforceable in accordance with its terms, except
                                         as enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, moratorium
                                         or other similar laws relating to or affecting the rights of creditors generally and
                                         by equitable principles, including those limiting the availability of specific performance,
                                         injunctive relief and other equitable remedies and those providing for equitable defenses.

 

		3.1.2.	Consents and Approvals. No consent, approval, authorization
                                         or order of, or filing with, any governmental body or any court is required to be obtained
                                         or made by such Seller for the consummation of the transactions contemplated by this
                                         Agreement.

 

		3.1.3.	No
                                         Violation of Law or Agreement. Neither the execution
                                         and delivery of this Agreement by such Seller, nor the consummation of the transactions
                                         contemplated hereby by such Seller, will violate any judgment, order, writ, decree, law,
                                         rule or regulation or agreement applicable to such Seller.

 

    	 	3	 

     

    

 

		3.1.4.	Ownership.
                                         Such Seller beneficially owns good and marketable title to the Convertible Notes being
                                         tendered into the Exchange Offer by it, and will beneficially own good title to the Exchange
                                         Common Stock Purchase Rights with respect to the Convertible Notes beneficially owned
                                         by such Seller that are accepted by the Company in the Exchange Offer, free and clear
                                         of any taxes or encumbrances; and assuming (a) the expiration of the Exchange Offer and
                                         (b) the acceptance by the Company of Convertible Notes beneficially owned by such Seller,
                                         such Seller will have conveyed to the Purchaser or its designee(s), if any, good title
                                         to the Exchange Common Stock Purchase Rights being transferred with respect to the Convertible
                                         Notes beneficially owned by such Seller that are accepted by the Company in the Exchange
                                         Offer, free and clear of any security interests, liens, adverse claims, taxes or encumbrances.
                                         

 

3.2.        Representations
and Warranties of the Purchaser. The Purchaser
hereby represents and warrants to, and agrees with, the Sellers as follows:

 

		3.2.1.	Organization, Authority, Execution and Enforceability.
                                         The Purchaser is duly organized, validly existing and in good standing under the laws
                                         of its jurisdiction of organization and has the right, power and authority to execute
                                         and deliver this Agreement and to consummate the transactions contemplated hereby. This
                                         Agreement has been duly authorized, executed and delivered by the Purchaser and constitutes
                                         the valid and binding obligation of the Purchaser, enforceable in accordance with its
                                         terms, except as enforceability may be limited by bankruptcy, insolvency, fraudulent
                                         transfer, moratorium or other similar laws relating to or affecting the rights of creditors
                                         generally and by equitable principles, including those limiting the availability of specific
                                         performance, injunctive relief and other equitable remedies and those providing for equitable
                                         defenses.

 

		3.2.2.	Investment Representations. The Purchaser and each
                                         designee of the Purchaser, if any, is an “accredited investor” as defined
                                         in Rule 501(a) promulgated under the U.S. Securities Act of 1933, as amended (the “Securities
                                         Act”), and has such knowledge and experience in financial and business matters
                                         that it is capable of evaluating the merits and risks of the transactions contemplated
                                         under this Agreement. The Purchaser agrees and each designee of the Purchaser, if any,
                                         shall agree that it will be acquiring the Exchange Common Stock Purchase Rights and the
                                         Shares issued in connection therewith for investment purposes, with no intention of distributing
                                         or reselling them or any interest therein. The Purchaser represents that it and each
                                         designee of the Purchaser, if any, has the capacity to evaluate the merits and risks
                                         of its investment in the Exchange Common Stock Purchase Rights and the Shares issued
                                         in connection therewith and to bear all economic risks of investment in the Exchange
                                         Common Stock Purchase Rights and the Shares issued in connection therewith, including
                                         a complete loss of its investment. The Purchaser represents that it and each designee
                                         of the Purchaser, if any, has had the opportunity to review such disclosure regarding
                                         the Company, its business, its financial condition and its prospects, including the Company’s
                                         publicly available SEC filings, as the Purchaser and each designee of the Purchaser,
                                         if any, has determined to be necessary in connection with the purchase of the Exchange
                                         Common Stock Purchase Rights. The Purchaser acknowledges on behalf of itself and each
                                         designee of the Purchaser, if any, that the Seller has not made any representation to
                                         the accuracy or completeness of any of the SEC filings of the Company.

 

    	 	4	 

     

    

 

		3.2.3.	Exempted Transaction. The Purchaser and each designee
                                         of the Purchaser, if any, understands that the Exchange Common Stock Purchase Rights
                                         and the Shares issued in connection therewith are being offered and sold to it in reliance
                                         on specific exemptions from the registration requirements of United States federal and
                                         state securities laws, have not been registered under the Securities Act or the securities
                                         laws of any state, and will be “restricted securities” as said term is defined
                                         in Rule 144 of the rules and regulations promulgated under the Securities Act.

 

		3.2.4.	Consents and Approvals. No consent, approval, authorization
                                         or order of, or filing with, any governmental body or any court is required to be obtained
                                         or made by the Purchaser and/or its designee(s) for the consummation of the transactions
                                         contemplated by this Agreement, other than the written approval of the Florida Office
                                         of Insurance Regulation, if applicable.

 

		3.2.5.	No
                                         Violation of Law or Agreement. Neither the execution
                                         and delivery of this Agreement by the Purchaser and/or its designee(s), nor the consummation
                                         of the transactions contemplated hereby by the Purchaser, will violate any judgment,
                                         order, writ, decree, law, rule or regulation or agreement applicable to the Purchaser.

 

		3.2.6.	Sufficiency of Financing. The Purchaser and/or its
                                         designee(s), if any, has, and at the Closing, will have sufficient immediately available
                                         funds to purchase, in accordance with Section 2.3.2, the Shares that it is hereby directing
                                         the Sellers to subscribe for in connection with such Sellers’ Exchange Common Stock
                                         Purchase Rights and to otherwise consummate the transactions contemplated by this Agreement.

 

3.3.        Sellers’
and Purchaser’s Joint Acknowledgement. The Sellers and the Purchaser hereby acknowledge and agree that the sale of the
Exchange Common Stock Purchase Rights under this Agreement is not a “Transfer” under and as defined in Section 6.14
of the Master Transaction Agreement.

 

3.4.        Indemnification.
Purchaser shall indemnify and hold each Seller and each of their respective officers, directors, Affiliates (as defined in the
Master Transaction Agreement), agents and employees (collectively, the “Indemnified Parties”) harmless from and against
any out-of-pocket loss, liability, taxes, claim, charge, assessed interest, judgment, fine, penalty, damage, fee or expense (including
reasonable legal, consultant, accounting and other professional fees and expenses and including any mitigation cost and any cost
of determining that there has been a breach under this Agreement) incurred by such Indemnified Party resulting from (a) any breach
of any representation and warranty of the Purchaser contained in this Agreement or document, agreement or instrument delivered
pursuant to or in connection with this Agreement or (b) any failure by the Purchaser to perform any covenant or agreement hereunder
(including, without limitation, the performance of the payment obligations described in Section 2.3.2) or under any document,
agreement or instrument contemplated hereby. The Indemnified Parties shall be third party beneficiaries of this Section 3.4, each
of which may enforce the provisions of this Section 3.4. The Purchaser acknowledges that the agreements contained in this Section
3.4 are an integral part of the transactions contemplated by this Agreement and that, without these agreements, the Sellers would
not enter into this Agreement.

 

    	 	5	 

     

    

 

4.     MISCELLANEOUS

 

4.1.        Survival
of Representations, Warranties and Covenants. The representations, warranties and covenants of each party contained herein
shall survive the closing of the sale of the Exchange Common Stock Purchase Rights. Each party may rely on such representations,
warranties and covenants irrespective of any investigation made, or notice or knowledge held by, it or any other person.

 

4.2.        Notices.
All notices and other communications by the Purchaser or the Sellers hereunder shall be in writing to the other party and shall
be deemed to have been duly given when delivered in person or by an overnight courier service, or sent via facsimile transmission
and verification received, or when posted by the United States postal service, registered or certified mail, return receipt requested
with postage prepaid.

 

4.3.        Assignment.
This Agreement shall not be assigned by either party without the prior written consent of the other party; provided, however,
that the obligation to make the payment for the Shares under Section 2.3.2, and the issuance of the Shares under Section 2.3.3,
may be assigned by the Purchaser without consent of the Sellers.

 

4.4.        Severability.
Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition
or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

4.5.        Further
Assurances. From and after the date hereof, upon the reasonable request of any party hereto, the other parties will execute
and deliver such instruments, documents or other writings as may be reasonably necessary or desirable to confirm and carry out
and to effectuate fully the intent and purposes of this Agreement.

 

4.6.        Entire
Agreement. This Agreement constitutes the entire agreement by the parties hereto and supersedes any other agreement, whether
written or oral, that may have been made or entered into between them relating to the matters contemplated hereby.

 

4.7.        Expenses.
Each of the parties agrees to pay its own expenses incident to this Agreement and the performance of its obligations hereunder.

 

    	 	6	 

     

    

 

4.8.        Governing
Law; Submission to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by and construed in accordance with
the laws of the State of New York without regard to conflicts of laws principles that would require the application of laws of
any other jurisdiction. Any legal action or proceeding in connection with this Agreement or the performance hereof shall be brought
in the state and federal courts located in the Borough of Manhattan, City, County and State of New York, and the parties hereby
irrevocably submit to the exclusive jurisdiction of such courts for the purpose of any such action or proceeding and agrees not
to assert, by way of motion, as a defense or otherwise, in any such action or proceeding, any claim that such party is not subject
personally to the jurisdiction of the above-named courts, that any such action or proceeding may not be brought or maintained
in one of the above-named courts should be dismissed on the grounds of forum non conveniens, should be transferred to any court
other than one of the above-named courts, or that this Agreement or the subject matter hereof may not be enforced in or by any
of the above-named courts. Each of the parties hereto hereby consents to service of process in any such action or proceeding in
any manner permitted by the laws of the State of New York, agrees that service of process by registered or certified mail, return
receipt requested, pursuant to Section 4.2 is reasonably calculated to give actual notice and waives and agrees not to assert
by way of motion, as a defense or otherwise, in any such action, suit or proceeding any claim that service of process made in
accordance with this Section 4.8 does not constitute good and sufficient service of process. THE PARTIES WAIVE THE RIGHT TO A
TRIAL BY JURY IN ANY DISPUTE ARISING UNDER OR IN CONNECTION WITH THIS AGREEMENT.

 

4.9.        Counterparts.
This Agreement may be executed in one or more counterparts (including by facsimile or other electronic transmission), each of
which shall be an original, but all of which together shall constitute one and the same instrument.

 

[Signature Page
Follows]

 

    	 	7	 

     

    

 

IN WITNESS WHEREOF, the Purchaser and the
Seller have caused this Agreement to be duly executed as of the date first above written.

 

	 	PJC
    Investments, LLC, as Purchaser
	 	 	 
	 	By:	/s/
    Patrick Curry
	 	 	Name:	Patrick Curry
	 	 	Title:	Managing Member
	 	 	 	 
	 	Ironsides
    P Fund L.P., as Seller
	 	 	 
	 	By:	Ironsides P Fund GP LLC,

    its General Partner
	 	 	 
	 	By:	/s/
    Robert Knapp
	 	Name:	Robert Knapp
	 	Title:	Manager
	 	 	 
	 	Ironsides
    Partners Special Situations Master Fund II L.P., as
    Seller
	 	 	 
	 	By:	Ironsides Partners Special Situations
    Fund GP LLC, its General Partner
	 	 	 
	 	By:	/s/
    Robert Knapp
	 	Name:	Robert Knapp
	 	Title:	Manager
	 	 	 
	 	aCKNOWLEDGED
        AND AGREED:

        eMERGENT
        Capital, INC., solely with respect to Sections 2.3.2, 2.3.3, 4.5 and 4.8. 

	 	 	 
	 	By:	/s/
    Antony Mitchell
	 	Name:	Antony Mitchell
	 	Title:	Chief Executive Officer

 

[Signature Page to
the to the Rights Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]